Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Qilian
company
About
Qilian is engaged in biological product research and development, medicine and chemical product production.
- 251 - 500
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- ¥12M
- Industries
- Health Care,Manufacturing,Medical,Pharmaceutical
- Founded date
- Aug 30, 2006
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Qilian focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥12M
Qilian has raised a total of
¥12M
in funding over 2 rounds. Their latest funding was raised on
May 26, 2015 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 26, 2015 | Post-IPO Equity | ¥12M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Qilian is funded by 1 investors.
Guotai Junan Securities
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Guotai Junan Securities
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
